Clinical Cancer Research

American Association for Cancer Research
United States
Impact factor
7.338 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Oncology & Cancer

Immunotherapy drug bolsters head and neck cancer treatment

A University of Cincinnati clinical trial that added an immunotherapy drug to standard of care treatment regimens has shown increased survival rates for head and neck cancer patients with intermediate risk features.

Oncology & Cancer

Study supports virotherapy as a potential treatment for brain tumors

A new study provides additional evidence of the efficacy of virotherapy for glioblastoma, the most deadly type of brain tumor. The research findings, published Feb. 1, 2022, in Clinical Cancer Research, indicate that an oncolytic ...

page 1 from 40